Jessica S. Fortin, BPharm, BSc, MSc, DVM, PhD

Affiliations: 
2018-2021 Pathobiology and Diagnostic Investigation Michigan State University, East Lansing, MI 
 2021- Basic Medical Sciences Purdue University, West Lafayette, IN, United States 
Area:
Medicinal chemistry, Protein misfolding and neurodegenerative diseases
Website:
https://vet.purdue.edu/directory/person.php?id=1635
Google:
"Jessica Fortin"
Mean distance: (not calculated yet)
 

Parents

Sign in to add mentor
René C.-Gaudreault grad student 2006-2008 Université Laval, Québec
Laurence H. Hurley grad student 2008-2010 University of Arizona
Scott E. Counts research scientist 2020-2021 Michigan State (Neurotree)
Dave Morgan research scientist 2020-2021 Michigan State (Neurotree)
Richard Neubig research scientist 2020-2021 Michigan State (Neurotree)

Children

Sign in to add trainee
Taiwo Ademoye grad student 2022- Purdue
Eduardo Ramirez grad student 2021-2024 Purdue
Ahmed Elbatrawy post-doc 2022- Purdue
Susantha K. Ganegamage post-doc 2022-2024 Purdue

Collaborators

Sign in to add collaborator
Babak Borhan collaborator 2021- Michigan State
Scott E. Counts collaborator 2021- (Neurotree)
Ulf Dettmer collaborator 2021- Harvard Medical School/Brigham and Women's Hospital
Dave Morgan collaborator 2021- (Neurotree)
Andy Hudmon collaborator 2022- (Neurotree)
Raluca Ostafe collaborator 2022- Purdue
George Perry collaborator 2022-
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Elbatrawy AA, Ademoye TA, Alnakhala H, et al. (2025) Inspecting the Triazole Scaffold as Powerful Antifibril Agents against 2N4R Tau and α-Synuclein Aggregates. Acs Omega. 10: 6721-6734
Elbatrawy AA, Ademoye TA, Alnakhala H, et al. (2024) Exploring the rhodanine universe: Design and synthesis of fluorescent rhodanine-based derivatives as anti-fibrillar and anti-oligomer agents against α-synuclein and 2N4R tau. Bioorganic & Medicinal Chemistry. 116: 117990
Ganegamage SK, Ademoye TA, Patel H, et al. (2024) Evaluation of Alpha-Synuclein and Tau Antiaggregation Activity of Urea and Thiourea-Based Small Molecules for Neurodegenerative Disease Therapeutics. Acs Chemical Neuroscience
Iwaide S, Murakami T, Sedghi Masoud N, et al. (2024) Classification of amyloidosis and protein misfolding disorders in animals 2024: A review on pathology and diagnosis. Veterinary Pathology. 3009858241283750
Haines MS, Ramirez E, Moore KBE, et al. (2024) Corrigendum to "Revisiting misfolding propensity of serum amyloid A1: Special focus on the signal peptide region" [Biochem. Biophys. Rep. 31 (2022) 1-9/101284]. Biochemistry and Biophysics Reports. 39: 101775
Horgan NG, McCarty AM, Hetak AA, et al. (2024) Understanding alpha-synuclein aggregation propensity in animals and humans. Biochemistry and Biophysics Reports. 39: 101810
Horgan NG, McCarty AM, Hetak AA, et al. (2024) Understanding alpha-synuclein aggregation propensity in animals and humans. Biochemistry and Biophysics Reports. 39: 101810
Elbatrawy AA, Ademoye TA, Alnakhala H, et al. (2024) Discovery of small molecule benzothiazole and indole derivatives tackling tau 2N4R and α-synuclein fibrils. Bioorganic & Medicinal Chemistry. 100: 117613
Ganegamage SK, Ramirez E, Alnakhala H, et al. (2023) 1,4-Diurea- and 1,4-Dithiourea-Substituted Aromatic Derivatives Selectively Inhibit α-Synuclein Oligomer Formation . Acs Omega. 9: 1216-1229
Ramirez E, Ganegamage SK, Min S, et al. (2023) Evaluation of N- and O-Linked Indole Triazines for a Dual Effect on α-Synuclein and Tau Aggregation Acs Chemical Neuroscience. 14: 3913-3927
See more...